AJP - Regu AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 252: R1015-R1018, 1987;
0363-6119/87 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenberg, D.
Right arrow Articles by Gibbs, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenberg, D.
Right arrow Articles by Gibbs, J.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 252, Issue 5 1015-R1018, Copyright © 1987 by American Physiological Society

ARTICLES

Infusion of CCK-8 into hepatic-portal vein fails to reduce food intake in rats

D. Greenberg, G. P. Smith and J. Gibbs

If the putative satiating effect of endogenous cholecystokinin (CCK) is produced through a circulating hormonal mechanism, then administration of exogenous CCK into the hepatic-portal vein should decrease meal size. To test this, one form of endogenous CCK, the C-terminal octapeptide CCK-8, was infused intraportally in doses of 4 and 8 micrograms/kg just prior to a test meal. Neither dose decreased food intake after intraportal infusion even though intraperitoneal administration of 4 micrograms/kg CCK-8 decreased meal size approximately 50% in the same rats. The results suggest that if endogenous CCK-8 has a satiating effect, it acts primarily through a paracrine mechanism.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C.-M. Lo, M. Xu, Q. Yang, S. Zheng, K. M. Carey, M. R. Tubb, W. S. Davidson, M. Liu, S. C. Woods, and P. Tso
Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R43 - R50.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Eisen, R. J. Phillips, N. Geary, E. A. Baronowsky, T. L. Powley, and G. P. Smith
Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R456 - R462.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. M. Simasko, J. Wiens, A. Karpiel, M. Covasa, and R. C. Ritter
Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1303 - R1313.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Burton-Freeman, D. W. Gietzen, and B. O. Schneeman
Cholecystokinin and serotonin receptors in the regulation of fat-induced satiety in rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R429 - R434.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online